QIAGEN Bioinformatics Customer Statistic
89% of surveyed organizations perform somatic clinical NGS variant calling (Secondary analysis) within their country.
This data was sourced directly from verified users of QIAGEN Digital Insights by TechValidate.
TechValidate verifies the identity and organizational affiliation of all participants that contribute to published research data. When research participants so desire, we also guarantee their anonymity so that they may share information honestly and freely.
More Research on QIAGEN Digital Insights
